Steven Cohen

Last Update: 05-15-2018

Number of Stocks: 905
Number of New Stocks: 283

Total Value: $23,920 Mil
Q/Q Turnover: 39%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

Steven Cohen' s Profile & Performance

Profile

Steven A. Cohen (also known as Stevie Cohen), a billionaire hedge fund investor, is the founder of SAC Capital Advisors, a Stamford, Connecticut based hedge fund which he continues to manage. Steven A. Cohen grew up in Great Neck, New York, and he attended the Wharton School of Business at the University of Pennsylvania. Steven A. Cohen lives in Greenwich, Connecticut with his wife and seven children.

Web Page:http://www.careers.sac.com/

Total Holding History

Performance of SAC Capital International Fund

YearReturn (%)S&P500 (%)Excess Gain (%)
20101515.05-0.1
200928.3926.352.0
2008-19-36.7917.8
3-Year Cumulative19.6 (6.1%/year)-8.1 (-2.8%/year)27.7 (8.9%/year)

Top Ranked Articles

Steven Cohen Buys Oil Company Alta Mesa Resources Investor takes 5% stake
Steven Cohen (Trades, Portfolio), founder of Point72 Asset Management, on Wednesday announced a purchase of 8,549,782 shares of Alta Mesa Resources (NASDAQ:AMR), an oil and gas company that formed and began public trading in February. Read more...
Steven Cohen Pours US Concrete Into Portfolio Guru boosts position 63.77%
Point 72 fund manager Steven Cohen (Trades, Portfolio) disclosed March 15 that he added 63.77% to his stake in US Concrete Inc. (NASDAQ:USCR). Read more...
Steven Cohen Dives Into Array BioPharma Guru keeps adding to positions in health care industry
On Sept. 11, Point72 manager Steven Cohen (Trades, Portfolio) invested in 6,766,507 shares of Array BioPharma Inc. (NASDAQ:ARRY), according to GuruFocus real-time picks. With this transaction, the guru increased his position 281.23%. Read more...
Steven Cohen Takes 5.7% Stake in Cancer Biopharma OncoSec Proprietary technology is in third stage to approval
Steven Cohen (Trades, Portfolio), chairman and CEO of hedge fund Point72 Asset Management, bought OncoSec Medical Inc. (NASDAQ:ONCS), stretching his sizable positioning in the healthcare industry. Read more...
World Wrestling Takes a Fall After WrestleMania 34 The stock has soared 69% in the last year and drawn a number of guru investors, but was down on Monday
It’s been a great year for the stock of the largest wrestling promotion company in the world. World Wrestling Entertainment Inc. (NYSE:WWE) saw a 16% jump in recent months of market volatility and has been a champion performer over the last 12 months of trading. Read more...
» More Steven Cohen Articles

Commentaries and Stories

  • Currently 4.00/5

Rating: 4.0/5 (1 vote)

Steven Cohen Takes Stake in Streaming Platform Roku Company's shares rise on deal with ESPN Steven Cohen - Steven Cohen Takes Stake In Streaming Platform Roku
Steven Cohen (Trades, Portfolio), founder of Point72 Asset Management, disclosed this week he established a 5.1% stake in Roku Inc. (NASDAQ:ROKU) on April 13. More...

STEVEN COHEN, POINT72, BUY, ROKU, STREAMING


  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

World Wrestling Takes a Fall After WrestleMania 34 The stock has soared 69% in the last year and drawn a number of guru investors, but was down on Monday Paul Tudor Jones, Steven Cohen, Louis Moore Bacon, - World Wrestling Takes A Fall After WrestleMania 34
It’s been a great year for the stock of the largest wrestling promotion company in the world. World Wrestling Entertainment Inc. (NYSE:WWE) saw a 16% jump in recent months of market volatility and has been a champion performer over the last 12 months of trading. More...

WRESTLING, STOCK, ENTERTAINMENT, VIEWS, CHAMPIONSHIP, WRESTLE, MANIA, MEDIA AND ENTERTAINMENT, VIEWERS, EPISODES, SMACKDOWN


  • Currently 4.50/5

Rating: 4.5/5 (2 votes)

Steven Cohen Pours US Concrete Into Portfolio Guru boosts position 63.77% Steven Cohen - Steven Cohen Pours US Concrete Into Portfolio
Point 72 fund manager Steven Cohen (Trades, Portfolio) disclosed March 15 that he added 63.77% to his stake in US Concrete Inc. (NASDAQ:USCR). More...

STEVEN COHEN


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Steven Cohen's Top Picks of the Fourth Quarter A biotech company and the maker of Budweiser top the list of new buys Steven Cohen - Steven Cohen's Top Picks Of The Fourth Quarter
Point72 Asset Management, Steven Cohen (Trades, Portfolio)’s asset management firm, opened three major positions in the final months of the year. More...

REGN, H, BUD, DIS, AZO, MASI, IBM,


  • Currently 4.67/5

Rating: 4.7/5 (3 votes)

Steven Cohen Buys Oil Company Alta Mesa Resources Investor takes 5% stake Steven Cohen - Steven Cohen Buys Oil Company Alta Mesa Resources
Steven Cohen (Trades, Portfolio), founder of Point72 Asset Management, on Wednesday announced a purchase of 8,549,782 shares of Alta Mesa Resources (NASDAQ:AMR), an oil and gas company that formed and began public trading in February. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Steven Cohen Takes Stake in Biotech Company Agenus Guru expands position in health care space Steven Cohen - Steven Cohen Takes Stake In Biotech Company Agenus
Point72 Asset Management leader Steven Cohen (Trades, Portfolio) disclosed this week he established a 6.13% stake in Agenus Inc. (NASDAQ:AGEN) on Feb. 21. More...

STEVEN COHEN, POINT72, BUY, AGENUS, HEALTHCARE


  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Steven Cohen Boosts Stake in Hyatt Hotels Guru real-time pick highlight Steven Cohen, Warren Buffett, Charlie Munger - Steven Cohen Boosts Stake In Hyatt Hotels
Steven Cohen (Trades, Portfolio), founder of Point72 Asset Management, disclosed Monday he added an additional 357,386 shares of Hyatt Hotels Corp. (NYSE:H) to his portfolio for $78.56 per share, according to GuruFocus real-time picks. More...

STEVEN COHEN, WARREN BUFFETT, CHARLIE MUNGER, REAL-TIME PICKS


  • Currently 4.00/5

Rating: 4.0/5 (1 vote)

Steven Cohen Bets on Airport Retail Company Hudson Guru takes stake in newly public company Steven Cohen - Steven Cohen Bets On Airport Retail Company Hudson
Point72 Asset Management leader Steven Cohen (Trades, Portfolio) disclosed Feb. 7 he established a 3.53% stake in travel retail company Hudson Ltd. (NYSE:HUD), which is a subsidiary of Switzerland-based Dufry AG (DUFRY). More...

STEVEN COHEN, POINT72, BUY, HUDSON, TRAVEL, RETAIL


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

American Axle Is a Bargain The stock still has room to run Jim Simons, Steven Cohen, Chuck Royce - American Axle Is A Bargain
American Axle & Manufacturing Holdings Inc. (NYSE:AXL) was established over 100 years ago by General Motors (NYSE:GM) and has been one of the automaker's biggest suppliers of engines and drivetrain components ever since. After a very close call during the housing crisis, when the stock traded below $1 per share, it has been roaring back to strength with year-over-year growth since 2009. More...

MANUFACTURING, AUTOMOTIVE, PARTS SUPPLIER, GENERAL MOTORS, GM, AMERICAN AXLE


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

5 Health Care Stocks in Gurus' Portfolios Amgen, Innoviva among stocks investors are buying Jim Simons, Steven Cohen, Joel Greenblatt - 5 Health Care Stocks In Gurus' Portfolios
According to the GuruFocus All-In-One Screener, the following health care stocks are popular among gurus. More...

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Steven Cohen Picks Up Position in First Bancorp Guru invests in bank holding company Steven Cohen - Steven Cohen Picks Up Position In First Bancorp
Point72 Asset Management leader Steven Cohen (Trades, Portfolio) disclosed a stake in First Bancorp (NASDAQ:FBNC) on Dec. 12. More...

STEVEN COHEN, POINT72, BUY, FIRST BANCORP


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Sage Therapeutics Rises 70% on Strong Phase 2 Results Company announced positive top-line results from clinical trial Steven Cohen, Paul Tudor Jones, Ron Baron - Sage Therapeutics Rises 70% On Strong Phase 2 Results
Sage Therapeutics Inc.'s (NASDAQ:SAGE) share price increased 70% at market open Dec. 7 as the company announced strong top-line results from its Phase 2 clinical trial of SAGE-217, a treatment for moderate to severe major depressive disorder (MDD) in adults. More...

STEVEN COHEN, PAUL TUDOR JONES, RON BARON


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Steven Cohen Boosts Stake in Radius Health Company has burgeoning treatment for osteoporosis Steven Cohen - Steven Cohen Boosts Stake In Radius Health
Investor Steven Cohen (Trades, Portfolio) took notice of fast-growing biopharmaceutical company Radius Health (NASDAQ:RDUS), boosting his holdings by 405.6% on Nov. 24, GuruFocus RealTime Picks reported. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

9 Stocks Steven Cohen Keeps Buying The guru added to these positions in the past 2 quarters Steven Cohen - 9 Stocks Steven Cohen Keeps Buying
Point72 Asset Management was founded by Steven Cohen (Trades, Portfolio) in 2014 as the successor to SAC Capital. In both the second and third quarters, the guru invested in the following stocks: More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Zeke Ashton Peppers Portfolio With 3 New Positions Guru added 1 ETF and 2 stocks in the 3rd quarter Zeke Ashton, Steven Cohen - Zeke Ashton Peppers Portfolio With 3 New Positions
Zeke Ashton (Trades, Portfolio), managing partner of Centaur Capital Partners, invests in stocks based upon value principles. In the third quarter, Ashton established positions in Facebook Inc. (NASDAQ:FB), Cheesecake Factory Inc. (NASDAQ:CAKE) and the SPDR S&P 500 (SPY) exchange-traded fund. More...

ZEKE ASHTON, STEVEN COHEN


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

The Curious Career of Steven Cohen Cohen has been spectacularly successful as an investor, but his image was tainted by an insider trading scandal. Additionally, his returns may not be as robust as the numbers suggest Steven Cohen, Warren Buffett - The Curious Career Of Steven Cohen
Few investment gurus have as controversial a record as Steven Cohen (Trades, Portfolio). He has won acclaim for outstanding returns over the long term, he’s been cursed for the way he does business by other Wall Streeters and he was at the center of an insider trading scandal, one that saw several of his traders convicted. More...

GURUS, STEVEN COHEN, SAC CAPITAL ADVISORS, POINT72, HEDGE FUND, SECURITIES AND EXCHANGE COMMISSION, INSIDER TRADING, MOSAIC THEORY OF INVESTING, FUNDAMENTALS, QUANTITATIVE, SHORT-TERM TRADING, SHORT S


  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Steven Cohen Takes Stake in Karyopharm Therapeutics Guru increases position in health care space Steven Cohen - Steven Cohen Takes Stake In Karyopharm Therapeutics
Point72 Asset Management founder Steven Cohen (Trades, Portfolio) established a holding in Karyopharm Therapeutics Inc. (NASDAQ:KPTI) on Nov. 3, further expanding his large positioning in the health care space. More...

COHEN, BUY, POINT72, KARYOPHARM, PHARMA, HEALTH CARE


  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Steven Cohen Takes 5.7% Stake in Cancer Biopharma OncoSec Proprietary technology is in third stage to approval Steven Cohen - Steven Cohen Takes 5.7% Stake In Cancer Biopharma OncoSec
Steven Cohen (Trades, Portfolio), chairman and CEO of hedge fund Point72 Asset Management, bought OncoSec Medical Inc. (NASDAQ:ONCS), stretching his sizable positioning in the healthcare industry. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Twitter Soars on Earnings Beat, Potential Profit Next Quarter Social network readjusted MAUs due to miscalculation Jim Simons,Steven Cohen,Jeremy Grantham,Paul Tudor - Twitter Soars On Earnings Beat, Potential Profit Next Quarter
Social media platform Twitter Inc. (NYSE:TWTR) reported its third-quarter results before the opening bell on Oct. 26, rising on the chance of a potential fourth-quarter profit. More...

TWITTER, 3Q, EARNINGS, BEAT


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Andreas Halvorsen Dives into Deciphera Pharma Company launches initial public offering and reports recent study results Andreas Halvorsen, Steven Cohen, Warren Buffett - Andreas Halvorsen Dives Into Deciphera Pharma
Andreas Halvorsen (Trades, Portfolio), chief investment officer of Viking Global Investors, invested in 2,479,867 shares of Deciphera Pharmaceuticals Inc. (NASDAQ:DCPH) for $19.73 per share on Oct. 2, according to GuruFocus real-time picks. More...

ANDREAS HALVORSEN, STEVEN COHEN, WARREN BUFFETT


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK